Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02611219 · ClinicalTrials.gov registry record · Early Phase 1
Deconditioning in Transplant
A Early Phase 1 study, sponsored by Washington University School of Medicine.
- Completed
- Registry status
- Early Phase 1
- Development phase
- 30
- Enrollment target
NCT02611219: Completed Early Phase 1 study, sponsored by Washington University School of Medicine.
NCT02611219 is a Early Phase 1 study that has completed, run by Washington University School of Medicine. The registered enrollment target is 30 participants, below the 53-participant average among 2,764 other Early Phase 1 trials with a reported enrollment target (43% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02611219, a Early Phase 1 study, has completed, sponsored by Washington University School of Medicine.
- COMPLETED
- Registry status
- Early Phase 1
- Development phase
- 30 participants
- Enrollment target
Study Summary
The purpose of this feasibility study is to test the potential for successful implementation of an intervention designed to study the effect of six hours out of bed time on the overall level of deconditioning in pediatric stem cell transplant (SCT) patients. Previous research has demonstrated that deconditioning occurs rapidly over the course of the hospitalization post-transplant and can negatively impact quality of life. By encouraging patients to be out of bed for six hours each day, it is anticipated that patients will experience less deconditioning than those patients who previously had no established minimum time out of the bed.
Primary Outcome
-Analyze the number of participants enrolled who continue through the 6 week clinic visit
Interventions
- OTHER General Health Module-Baseline Adolescent-Self Report (13-18 years)
- OTHER General Health Module-Follow Up Adolescent-Self Report (13-18 years)
- OTHER General Health Module-Baseline Parent Report-Adolescent (13-18 years)
- OTHER General Health Module-Follow Up Parent Report-Adolescent (13-18 years)
- OTHER General Health Module-Baseline Parent Report-School Age (5-12 years)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 30 participants |
| Start Date | 2015-03 |
| Est. Completion | 2016-04 |
| Phase | Early Phase 1 |
What the finished NCT02611219 record still lists
NCT02611219 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 30 participants, a relatively small participant target, below the 53-participant average among 2,764 other Early Phase 1 trials with a reported enrollment target (43% lower).
The record links to 0 conditions, and to 5 interventions - of which General Health Module-Baseline Adolescent-Self Report (13-18 years) is the first listed.
NCT02611219 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02611219 about?
NCT02611219 is a clinical study titled "Deconditioning in Transplant". The purpose of this feasibility study is to test the potential for successful implementation of an intervention designed to study the effect of six hours out of bed time on the overall level of deconditioning in pediatric stem cell transplant (SCT) patients. Previous research has demonstrated that d...
What is the current status of trial NCT02611219?
This trial is currently completed. It is a Early Phase 1 study. The enrollment target is 30 participants. The study started on 2015-03. Estimated completion is 2016-04.
What interventions are being tested in trial NCT02611219?
The interventions under investigation include: General Health Module-Baseline Adolescent-Self Report (13-18 years) (OTHER), General Health Module-Follow Up Adolescent-Self Report (13-18 years) (OTHER), General Health Module-Baseline Parent Report-Adolescent (13-18 years) (OTHER), General Health Module-Follow Up Parent Report-Adolescent (13-18 years) (OTHER), General Health Module-Baseline Parent Report-School Age (5-12 years) (OTHER).
Who is sponsoring clinical trial NCT02611219?
This trial is sponsored by Washington University School of Medicine, which has 1,502 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT02611219's enrollment target sits among peer trials
30 807th of 2000 higher than 1,074 of 2,000 other Early Phase 1 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Early Phase 1 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00977977 · 30 participants · Phase 2
Rituximab Plus Cyclosporine in Idiopathic Membranous Nephropathy
- NCT01459107 · 30 participants · Phase 2
Human Upper Extremity Allotransplantation
- NCT01666080 · 30 participants · NA
Second or Greater Allogeneic Hematopoietic Stem Cell Transplant Using Reduced Intensity Conditioning (RIC)
- NCT01720836 · 30 participants · Phase 1
Study of the Immune Response of MUC1 (Mucin1) Peptide Vaccine for Non-small Cell Lung Cancer
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia